Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Sell |
299,649
-25,821
| -8% | -$1.72M | 0.03% | 418 |
|
|
2026
Q1 | $20.4M | Buy |
325,470
+11,017
| +4% | +$767K | 0.03% | 395 |
|
|
2025
Q4 | $20.9M | Buy |
314,453
+8,294
| +3% | +$536K | 0.04% | 382 |
|
|
2025
Q3 | $20.6M | Buy |
306,159
+14,697
| +5% | +$1.16M | 0.04% | 374 |
|
|
2025
Q2 | $25.4M | Buy |
291,462
+18,667
| +7% | +$1.46M | 0.05% | 311 |
|
|
2025
Q1 | $18.6M | Buy |
272,795
+31,893
| +13% | +$2.6M | 0.04% | 355 |
|
|
2024
Q4 | $18.7M | Buy |
240,902
+63,622
| +36% | +$4.71M | 0.05% | 336 |
|
|
2024
Q3 | $11.9M | Buy |
177,280
+4,405
| +3% | +$362K | 0.03% | 404 |
|
|
2024
Q2 | $19.6M | Buy |
172,875
+42,620
| +33% | +$5.39M | 0.05% | 351 |
|
|
2024
Q1 | $18.1M | Buy |
130,255
+33,423
| +35% | +$4.2M | 0.06% | 355 |
|
|
2023
Q4 | $12M | Sell |
96,832
-140,565
| -59% | -$14.4M | 0.04% | 423 |
|
|
2023
Q3 | $22.1M | Buy |
237,397
+33,441
| +16% | +$3.77M | 0.09% | 283 |
|
|
2023
Q2 | $26.2M | Buy |
203,956
+96,413
| +90% | +$11.7M | 0.11% | 227 |
|
|
2023
Q1 | $12.5M | Sell |
107,543
-37,230
| -26% | -$4.17M | 0.06% | 426 |
|
|
2022
Q4 | $16.4M | Sell |
144,773
-120,374
| -45% | -$13.2M | 0.08% | 349 |
|
|
2022
Q3 | $21.4M | Sell |
265,147
-26,403
| -9% | -$2.24M | 0.12% | 215 |
|
|
2022
Q2 | $21.7M | Buy |
291,550
+96,410
| +49% | +$8.8M | 0.12% | 230 |
|
|
2022
Q1 | $25M | Buy |
195,140
+71,264
| +58% | +$7.8M | 0.12% | 183 |
|
|
2021
Q4 | $16.6M | Sell |
123,876
-1,168
| -0.9% | -$168K | 0.07% | 273 |
|
|
2021
Q3 | $17.1M | Sell |
125,044
-4,888
| -4% | -$616K | 0.08% | 259 |
|
|
2021
Q2 | $13.9M | Buy |
129,932
+6,572
| +5% | +$631K | 0.06% | 304 |
|
|
2021
Q1 | $11.1M | Sell |
123,360
-692
| -0.6% | -$65K | 0.05% | 317 |
|
|
2020
Q4 | $11.5M | Buy |
124,052
+5,264
| +4% | +$470K | 0.06% | 298 |
|
|
2020
Q3 | $12.2M | Sell |
118,788
-3,620
| -3% | -$378K | 0.07% | 236 |
|
|
2020
Q2 | $12.4M | Sell |
122,408
-59,120
| -33% | -$5.29M | 0.08% | 218 |
|
|
2020
Q1 | $12.2M | Buy |
181,528
+54,316
| +43% | +$3.38M | 0.09% | 191 |
|
|
2019
Q4 | $6.96M | Sell |
127,212
-184
| -0.1% | -$8.73K | 0.04% | 371 |
|
|
2019
Q3 | $4.75M | Sell |
127,396
-1,656
| -1% | -$64.3K | 0.03% | 439 |
|
|
2019
Q2 | $4.83M | Sell |
129,052
-2,836
| -2% | -$89.1K | 0.03% | 460 |
|
|
2019
Q1 | $3.93M | Buy |
+131,888
| New | +$4.63M | 0.03% | 522 |
|
Other funds holding DXCM
Aviva's DXCM Position: Q2 2026 in Review
Aviva reduced its DexCom (DXCM) stake by 7.9% in Q2 2026, selling an estimated $1.72M and leaving 299,649 shares worth $20.2M. The position accounts for 0.03% of the portfolio, ranked #418.
Aviva first reported a position in DXCM in Q1 2019 and has held it in 30 quarters since. The position peaked at $26.2M in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Aviva held 299,649 shares of DexCom worth $20.2M as of Q2 2026.
- Aviva sold 25,821 DexCom shares in Q2 2026, an estimated $1.72M.
- DexCom made up 0.03% of Aviva's portfolio in Q2 2026, its #418 holding.
- Aviva first reported a position in DexCom in Q1 2019 and has held it in 30 quarters since.
- Aviva's DexCom position peaked at $26.2M in Q2 2023.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.